Research

There have been no truly novel medicinal breakthroughs in treatments for mental illness or psychological distress over the past 50 years.

Professor Arthur Christopoulos, FAA FAHMS
Final Report, Royal Commission into Victoria’s Mental Health System, Vol. 5, p. 156.

The Neuromedicines Discovery Centre (NDC) takes a holistic approach to mental health conditions, tackling the problem at scale via a comprehensive, matrixed approach: multiple medicines and regimens evaluated in different mental health conditions across representative patient cohorts, backed up by world-class research into the development of next generation therapeutics and rigorously designed clinical trials.

An example is psychedelic research, which to date has been conducted in a piecemeal fashion. With limited funds, often from small philanthropic grants, researchers have been restricted to narrow enquiries: most often a single drug and regimen, tested against one condition in a small patient cohort – often in an open-label manner with minimal blinding and limited placebo controls.

To deliver mental health innovation, we’ve organised our research into three themes:

What is neuromedicine-assisted psychotherapy?

Neuromedicine-assisted psychotherapy refers to the use of psychoactive medicines (including those sometimes referred to as ‘psychedelics’) together with psychological therapy.

Find out more